Annual CFF
$12.00 M
-$2.76 M-18.69%
December 31, 2023
Summary
- As of February 8, 2025, VTVT annual cash flow from financing activities is $12.00 million, with the most recent change of -$2.76 million (-18.69%) on December 31, 2023.
- During the last 3 years, VTVT annual CFF has fallen by -$7.47 million (-38.38%).
- VTVT annual CFF is now -90.30% below its all-time high of $123.64 million, reached on December 31, 2015.
Performance
VTVT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$2.46 M
+$2.46 M+100.00%
September 30, 2024
Summary
- As of February 8, 2025, VTVT quarterly cash flow from financing activities is $2.46 million, with the most recent change of +$2.46 million (+100.00%) on September 30, 2024.
- Over the past year, VTVT quarterly CFF has increased by +$2.46 million (+100.00%).
- VTVT quarterly CFF is now -97.64% below its all-time high of $104.44 million, reached on September 30, 2015.
Performance
VTVT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$52.33 M
+$1.99 M+3.95%
September 30, 2024
Summary
- As of February 8, 2025, VTVT TTM cash flow from financing activities is $52.33 million, with the most recent change of +$1.99 million (+3.95%) on September 30, 2024.
- Over the past year, VTVT TTM CFF has increased by +$1.99 million (+3.95%).
- VTVT TTM CFF is now -59.99% below its all-time high of $130.77 million, reached on September 30, 2015.
Performance
VTVT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VTVT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -18.7% | +100.0% | +4.0% |
| 3 y3 years | -38.4% | +100.0% | +140.3% |
| 5 y5 years | -27.8% | -70.3% | +112.6% |
VTVT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -55.5% | at low | -95.1% | +973.4% | at high | +360.9% |
| 5 y | 5-year | -55.5% | at low | -95.1% | +973.4% | at high | +360.9% |
| alltime | all time | -90.3% | +60.0% | -97.6% | +973.4% | -60.0% | >+9999.0% |
VTv Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $2.46 M(>+9900.0%) | $52.33 M(+4.0%) |
| Jun 2024 | - | $0.00(-100.0%) | $50.34 M(0.0%) |
| Mar 2024 | - | $50.14 M(<-9900.0%) | $50.34 M(+319.6%) |
| Dec 2023 | $12.00 M(-18.7%) | -$282.00 K(-159.6%) | $12.00 M(-24.8%) |
| Sep 2023 | - | $473.00 K(>+9900.0%) | $15.95 M(-26.8%) |
| Jun 2023 | - | $0.00(-100.0%) | $21.78 M(-18.8%) |
| Mar 2023 | - | $11.81 M(+222.0%) | $26.82 M(+81.8%) |
| Dec 2022 | $14.75 M(-45.3%) | $3.67 M(-41.8%) | $14.75 M(+30.0%) |
| Sep 2022 | - | $6.30 M(+25.1%) | $11.35 M(-34.7%) |
| Jun 2022 | - | $5.04 M(-2068.8%) | $17.38 M(-7.2%) |
| Mar 2022 | - | -$256.00 K(-196.2%) | $18.72 M(-30.6%) |
| Dec 2021 | $26.98 M(+38.6%) | $266.00 K(-97.8%) | $26.98 M(-17.9%) |
| Sep 2021 | - | $12.32 M(+93.1%) | $32.84 M(+53.6%) |
| Jun 2021 | - | $6.38 M(-20.2%) | $21.39 M(-8.1%) |
| Mar 2021 | - | $8.00 M(+30.5%) | $23.28 M(+19.6%) |
| Dec 2020 | $19.47 M(-14.9%) | $6.13 M(+605.6%) | $19.47 M(+4.5%) |
| Sep 2020 | - | $869.00 K(-89.5%) | $18.62 M(-24.3%) |
| Jun 2020 | - | $8.28 M(+97.7%) | $24.61 M(+34.3%) |
| Mar 2020 | - | $4.19 M(-20.7%) | $18.33 M(-19.8%) |
| Dec 2019 | $22.87 M | $5.29 M(-22.9%) | $22.87 M(+7.0%) |
| Sep 2019 | - | $6.86 M(+242.9%) | $21.37 M(-8.6%) |
| Jun 2019 | - | $2.00 M(-77.1%) | $23.38 M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $8.73 M(+130.5%) | $25.34 M(+52.5%) |
| Dec 2018 | $16.61 M(+121.5%) | $3.79 M(-57.3%) | $16.61 M(+29.5%) |
| Sep 2018 | - | $8.87 M(+124.1%) | $12.83 M(+224.1%) |
| Jun 2018 | - | $3.96 M(>+9900.0%) | $3.96 M(>+9900.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2017 | $7.50 M(-36.4%) | $0.00(0.0%) | $7.50 M(-61.3%) |
| Sep 2017 | - | $0.00(0.0%) | $19.37 M(+0.3%) |
| Jun 2017 | - | $0.00(-100.0%) | $19.32 M(+0.1%) |
| Mar 2017 | - | $7.50 M(-36.8%) | $19.29 M(+63.6%) |
| Dec 2016 | $11.79 M(-90.5%) | $11.87 M(<-9900.0%) | $11.79 M(<-9900.0%) |
| Sep 2016 | - | -$55.00 K(+129.2%) | -$79.00 K(-100.1%) |
| Jun 2016 | - | -$24.00 K(<-9900.0%) | $104.42 M(-9.1%) |
| Mar 2016 | - | $0.00(0.0%) | $114.88 M(-7.1%) |
| Dec 2015 | $123.64 M(+300.0%) | $0.00(-100.0%) | $123.64 M(-5.4%) |
| Sep 2015 | - | $104.44 M(+900.6%) | $130.77 M(+318.0%) |
| Jun 2015 | - | $10.44 M(+19.1%) | $31.29 M(+5.8%) |
| Mar 2015 | - | $8.76 M(+23.0%) | $29.56 M(-4.4%) |
| Dec 2014 | $30.91 M(-24.2%) | $7.12 M(+43.5%) | $30.91 M(+29.9%) |
| Sep 2014 | - | $4.96 M(-43.0%) | $23.79 M(+26.4%) |
| Jun 2014 | - | $8.71 M(-13.9%) | $18.83 M(+86.1%) |
| Mar 2014 | - | $10.12 M | $10.12 M |
| Dec 2013 | $40.80 M | - | - |
FAQ
- What is vTv Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for vTv Therapeutics?
- What is vTv Therapeutics annual CFF year-on-year change?
- What is vTv Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for vTv Therapeutics?
- What is vTv Therapeutics quarterly CFF year-on-year change?
- What is vTv Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for vTv Therapeutics?
- What is vTv Therapeutics TTM CFF year-on-year change?
What is vTv Therapeutics annual cash flow from financing activities?
The current annual CFF of VTVT is $12.00 M
What is the all time high annual CFF for vTv Therapeutics?
vTv Therapeutics all-time high annual cash flow from financing activities is $123.64 M
What is vTv Therapeutics annual CFF year-on-year change?
Over the past year, VTVT annual cash flow from financing activities has changed by -$2.76 M (-18.69%)
What is vTv Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of VTVT is $2.46 M
What is the all time high quarterly CFF for vTv Therapeutics?
vTv Therapeutics all-time high quarterly cash flow from financing activities is $104.44 M
What is vTv Therapeutics quarterly CFF year-on-year change?
Over the past year, VTVT quarterly cash flow from financing activities has changed by +$2.46 M (+100.00%)
What is vTv Therapeutics TTM cash flow from financing activities?
The current TTM CFF of VTVT is $52.33 M
What is the all time high TTM CFF for vTv Therapeutics?
vTv Therapeutics all-time high TTM cash flow from financing activities is $130.77 M
What is vTv Therapeutics TTM CFF year-on-year change?
Over the past year, VTVT TTM cash flow from financing activities has changed by +$1.99 M (+3.95%)